학술논문

CDK inhibition results in pharmacologic BRCAness increasing sensitivity to olaparib in BRCA1-WT and olaparib resistant in Triple Negative Breast Cancer
Document Type
Article
Source
In: Cancer Letters. (Cancer Letters, 1 May 2024, 589)
Subject
Language
English
ISSN
18727980
03043835